Several recent finalized ICH guidelines have been released in the last 12 months. Of importance for the types of products we represent at Cosmetics Alliance are: Q12 Technical […]
The Natural and Non-prescription Health Products Directorate (NNHPD) has launched a dedicated landing page for Non-prescription Drugs (NPDs) to provide clearer guidance for industry stakeholders. Key Highlights: […]
Bill C-15 received Royal Assent on March 26, 2026. Embedded in this budget bill (at section 597 (1), which amends 74.01 (1) (b.2) of the Competition Act) amended […]
Following CA’s Notice to members on March 10, 2026, which outlined Health Canada’s more flexible approach for disclosing fragrance allergen concentrations on the Cosmetic Notification Form (CNF). Under these […]
PRODUCT APPLICATIONS: Class I Applications: Currently meeting service standards. Class II Applications (meeting Workload Management eligibility criteria): Prioritized Class 2 applications are issued a decision within the […]
On March 25, 2026, the Government of Canada published Order 2026-87-20-01 in the Canada Gazette, Part II, introducing significant changes to the Domestic Substances List (DSL) under the Canadian […]
On March 19, 2026, Environment and Climate Change Canada and Health Canada released an update to the Chemicals Management Plan (CMP) Risk Assessment Publication Plan. This update outlines anticipated […]
As reported in our January 14th Regulatory Essentials the government has “deferred” Phase 2 and 3 of the Federal Plastics Registry. This was done in response to the advocacy […]
On 9 February 2026, the Office for Product Safety and Standards (OPSS) published a new Statutory Instrument (SI) amending the Annexes of the UK Cosmetics Regulation. Key changes include adding N,N’-methylenediacrylamide, […]
Below is a copy of the following Natural Health Products Site Licensing and Good Manufacturing Practices Inspection Bulletin. The primary focus of this bulletin is the transition from ePost […]
